✦ LIBER ✦

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice

✍ Scribed by Hattangadi, Jona A.; Chen, Ming-Hui; Braccioforte, Michelle H.; Moran, Brian J.; D’Amico, Anthony V.

Book ID: 122609747
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 116 KB
Volume: 10
Category: Article
ISSN: 1538-4721
DOI: 10.1016/j.brachy.2011.01.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Supplemental External Beam Radiot

Use of Supplemental External Beam Radiotherapy in Men with Low-risk Prostate Cancer undergoing Brachytherapy

✍ Cheung, A.K.; Chen, M.; Moran, B.J.; Braccioforte, M.H.; Dosoretz, D.E.; Saleniu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Hormonal Therapy or External-Beam Radiat

Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer

✍ Jonathan E. Rosenberg; Ming-Hui Chen; Paul L. Nguyen; Michelle H. Braccioforte; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 268 KB

Short- vs long-term androgen suppression

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate

✍ Anthony V. D'Amico; James W. Denham; Michel Bolla; Laurence Collette; David S. L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## BACKGROUND The study evaluated whether the use of 3 years as compared with 6 months of androgen suppression therapy (AST) combined with external beam radiation therapy (RT) in the treatment of high‐risk prostate cancer was associated with prolonged survival in advanced age men. ##

The addition of low-dose-rate brachyther

The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer

✍ Mark Shilkrut; Gregory S. Merrick; P. William McLaughlin; Matthew H. Stenmark; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Single-Fraction High-Dose-Rate Brachythe

Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer – Long Term Results

✍ Fabio L. Cury; Marie Duclos; Armen Aprikian; Horacio Patrocinio; Wassim Kassouf; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Impact of age on biochemical control in

Impact of age on biochemical control in a cohort of intermediate- and high-risk prostate cancer patients treated with high-dose-rate brachytherapy boost combined with pelvic external beam radiation therapy

✍ Amy L. Limbacher; Michel Ghilezan; Gary Gustafson; Peter Y. Chen; Christine Mitc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB